ERLOTINIB IN NON-SMALL CELL LUNG CANCER: ANALYSIS OF TOXICITY AND EFFICACY IN CLINICAL PRACTICE

被引：0
|
作者：
Alexandre, Maria Teresa A. [1 ]
Ip, Joana [1 ]
Duarte, Isabel [1 ]
Almodovar, Teresa [1 ]
Da Costa, Jose Duro [1 ]
机构：
[1] Inst Portugues Oncol Lisboa, Lisbon, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Lung cancer; Erlotinib; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.24-054
引用
收藏
页码：S1326 / S1327
页数：2
相关论文
共 50 条
  • [21] Erlotinib (Tarceva) for advanced non-small cell lung cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1205): : 25 - 26
  • [22] Experience with erlotinib in the treatment of non-small cell lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) : 146 - 163
  • [23] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Marco Platania
    Francesco Agustoni
    Barbara Formisano
    Milena Vitali
    Monika Ducceschi
    Filippo Pietrantonio
    Nicoletta Zilembo
    Francesco Gelsomino
    Sara Pusceddu
    Roberto Buzzoni
    Targeted Oncology, 2011, 6 : 181 - 186
  • [24] Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
    Platania, Marco
    Agustoni, Francesco
    Formisano, Barbara
    Vitali, Milena
    Ducceschi, Monika
    Pietrantonio, Filippo
    Zilembo, Nicoletta
    Gelsomino, Francesco
    Pusceddu, Sara
    Buzzoni, Roberto
    TARGETED ONCOLOGY, 2011, 6 (03) : 181 - 186
  • [25] ERLOTINIB RELATED TOXICITY IN ELDERLY PATIENTS AFFECTED BY NON-SMALL CELL LUNG CANCER (NSCLC)
    Palazzo, A.
    Iacovelli, R.
    Mazzoli, M.
    Mancini, M. L.
    Passaro, A.
    Altavilla, A.
    Conte, D.
    Naso, G.
    Cortesi, E.
    LUNG CANCER, 2009, 64 : S55 - S55
  • [26] Erlotinib: Recent clinical results and ongoing studies in non-small cell lung cancer
    Perez-Soler, Roman
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4589S - 4592S
  • [27] Toxicity and efficacy of chemotherapy for non-small cell lung cancer with cavitary lesions
    Tokito, Takaaki
    Shukuya, Takehito
    Akamatsu, Hiroaki
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Mori, Keita
    Yamamoto, Nobuyuki
    RESPIRATORY INVESTIGATION, 2014, 52 (03) : 184 - 189
  • [28] The efficacy of erlotinib for patients with non-small cell lung cancer with wild type of EGFR mutations
    Kobayashi, Takashi
    Koizumi, Tomonobu
    Tanabe, Tsuyoshi
    Tsushima, Kenji
    Urushihata, Kazuhisa
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Kubo, Keishi
    Koyama, Shigeru
    Ooura, Nariaki
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S690 - S690
  • [29] The Efficacy of Pistacia Terebinthus Soap in the Treatment of Erlotinib-Induced Skin Toxicity in Non-Small Cell Lung Cancer Patients
    Tastekin, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2312 - S2312
  • [30] Efficacy of erlotinib and celecoxib for patients with advanced non-small cell lung cancer: A retrospective study
    Jin, Yi-Hua
    Li, Wei-Hong
    Bai, Yan
    Ni, Lei
    MEDICINE, 2019, 98 (10)
12345